ArticleGenes & diseases2026

PAK1 inhibition synergistically enhances the anti-tumor efficacy of PARP inhibitors in ovarian cancers.

Changying Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.